Intellectual Property Cases
Cases 1 - 10 of 12
RSS Feed | View as table | Sort by filed date
Exelixis, Inc. v. Cipla Ltd. et al
as 1:2024cv00565
Plaintiff: Exelixis, Inc.
Defendant: Cipla Ltd. and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. Cipla Ltd. et al
as 1:2023cv00287
Plaintiff: Exelixis, Inc.
Defendant: Cipla Ltd. and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. Teva Pharmaceutical Industries Limited et al
as 1:2022cv01168
Plaintiff: Exelixis, Inc.
Defendant: Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. MSN Laboratories Private Limited et al
as 1:2022cv00945
Plaintiff: Exelixis, Inc.
Defendant: MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. MSN Laboratories Private Limited et al
as 1:2022cv00228
Plaintiff: Exelixis, Inc.
Defendant: MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. Teva Pharmaceutical Industries Limited et al
as 1:2021cv00871
Plaintiff: Exelixis, Inc.
Defendant: Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals Development, Inc.
Cause Of Action: 35 U.S.C. § 271
Exelixis, Inc. v. MSN Laboratories Private Limited et al
as 1:2020cv00633
Plaintiff: Exelixis, Inc.
Defendant: MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Exelixis, Inc. v. MSN Laboratories Private Limited et al We have downloadable decisions or orders for this case
as 1:2019cv02017
Plaintiff: Exelixis, Inc.
Defendant: MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Exelixis, Inc. v. Camden Partners Holdings, LLC et al
as 3:2017cv01106
Plaintiff: Exelixis, Inc.
Defendant: Camden Partners Holdings, LLC, Camden Partners Exelixis Fund, L.P. and Camden Partners Exelixis, LLC
Cause Of Action: 15 U.S.C. § 44
Exelixis, Inc. v. Kappos
as 1:2012cv01284
Plaintiff: Exelixis, Inc.
Defendant: David J. Kappos
Cause Of Action: 35 U.S.C. § 154 AIA Appeal of Patent Term Adjustment Determination

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?